ADLM 2025: Laboratory Medicine Takes Center Stage in Transforming Global Healthcare
The Association for Diagnostics & Laboratory Medicine (ADLM), formerly known as the American Association for Clinical Chemistry (AACC), will host its annual meeting, ADLM 2025, from July 27-31 in Chicago. This year’s meeting, held in partnership with the Canadian Society of Clinical Chemists (CSCC), promises to be a dynamic exploration of the transformative power of laboratory medicine in addressing critical global health challenges. The event will feature a diverse range of topics, from the integration of artificial intelligence (AI) in clinical settings to the pervasive impact of plastics on human health, and the exciting potential of genomics and microbiome medicine in personalized healthcare. The conference will also tackle the pressing issue of medical misinformation and its detrimental effects on public health.
Unlocking the Potential of Genomics for Rare Disease Diagnosis and Treatment
One of the key highlights of ADLM 2025 will be a plenary session led by Dr. Heidi L. Rehm, the 2025 Wallace H. Coulter Lectureship awardee and chief genomics officer at Massachusetts General Hospital. Dr. Rehm’s presentation will focus on the groundbreaking advancements in genomics, the study of an individual’s complete set of genes, and its potential to revolutionize the diagnosis and treatment of rare diseases. While individually rare, these conditions collectively affect millions of people. Dr. Rehm will discuss cutting-edge research strategies, technologies, and analytical methods employed to identify the genetic underpinnings of rare diseases. Furthermore, she will explore innovative approaches to global data sharing and how genomics can pave the way for new treatment and testing modalities, offering hope to patients and their families.
Navigating the Challenges and Opportunities of AI Integration in Healthcare
The integration of artificial intelligence (AI) in healthcare holds immense promise for streamlining workflows, reducing healthcare worker burnout, and improving patient outcomes. However, despite the FDA’s approval of numerous AI-powered medical devices, real-world implementation has been limited. In a dedicated plenary session, Dr. Judy Wawira Gichoya, associate professor of interventional radiology and informatics at Emory University, will address the challenges and opportunities associated with AI integration in clinical settings. Dr. Gichoya will delve into the complexities of implementing AI algorithms, discuss real-world examples of successful and unsuccessful deployments, and offer valuable insights to guide future integration efforts. Her presentation will provide a balanced perspective on the realistic potential of AI in transforming healthcare.
Combating the Infodemic: Addressing the Dangers of Medical Misinformation
In an era of rampant misinformation, separating fact from fiction in healthcare has become increasingly challenging. The spread of conspiracy theories and false medical claims, often fueled by social media and celebrity endorsements, poses a significant threat to public health. Professor Timothy Caulfield, research director of the Health Law Institute at the University of Alberta, Canada, will deliver a thought-provoking plenary session on the dangers of medical misinformation. He will dissect the cultural forces driving the spread of falsehoods, including cognitive biases, fearmongering, and the influence of social media. Professor Caulfield will also provide practical strategies for individuals and organizations to combat misinformation and promote evidence-based healthcare decisions.
Harnessing the Power of Microbiome Medicine for Personalized Care
The human microbiome, the complex community of microbes residing within our bodies, plays a crucial role in human health. Alterations in the microbiome have been linked to various health conditions, including allergies, neurological disorders, and metabolic diseases. Dr. Jack Gilbert, director of the Microbiome and Metagenomics Center at the University of California, San Diego, will explore the emerging field of microbiome medicine in his plenary session. He will share insights from microbiome-wide association studies, demonstrating how these findings can inform the development of personalized approaches to diet and medicine. Dr. Gilbert’s presentation will highlight the potential of microbiome-based therapies to revolutionize healthcare.
Addressing the Urgent Threat of Plastics to Human Health
While the visible pollution caused by plastics is widely recognized, the health risks associated with plastic additives, such as per- and polyfluoroalkyl substances (PFAS), are less understood. These chemicals have been detected in human populations, particularly in communities near production facilities, raising concerns about their potential health effects. Dr. Leonardo Trasande, professor of pediatrics at New York University Grossman School of Medicine, will address the emerging science on PFAS exposure and its impact on human health. He will discuss strategies for reducing exposure through behavioral and regulatory interventions, as well as the growing calls for PFAS testing in clinical laboratories.
ADLM 2025: A Showcase of Innovation and Collaboration in Laboratory Medicine
ADLM 2025 promises to be a pivotal event, showcasing the diverse and vital role of laboratory medicine in advancing healthcare. From genomics and AI to the microbiome and the health implications of plastics, the meeting will cover a wide spectrum of critical topics. The event will also feature a comprehensive Clinical Lab Expo, where more than 800 exhibitors will display the latest diagnostic technologies. ADLM 2025 provides a unique platform for laboratory professionals, researchers, clinicians, and industry leaders to connect, collaborate, and share knowledge, ultimately driving innovation and improving patient care. Media registration for the event is free, allowing journalists to report on the latest developments in this rapidly evolving field.